JMS Co

JMS Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of JMS Co (7702.T) as of Nov 2, 2026 is 156.31 %. In the previous year, CapEx to Operating Cash Flow Ratio was 197.55 % — a change of -20.87% (lower).

CapEx/OCF

156.31 %

YoY

-20.87%

Last updated:

CapEx to Operating Cash Flow Ratio of JMS Co is 2026 156.31 % . CapEx to Operating Cash Flow Ratio of JMS Co was 2025 197.55 % . It decreases by -20.87% lower compared to the previous year.

The JMS Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2019
68.62 JPY
Jan 1, 2020
92.62 JPY
Jan 1, 2021
87.14 JPY
Jan 1, 2022
74.13 JPY
Jan 1, 2023
143.10 JPY
Jan 1, 2024
84.14 JPY
Jan 1, 2025
197.55 JPY
Jan 1, 2026
156.31 JPY
The JMS Co CapEx/OCF history
YEARCapEx/OCFYoY
156.31 %-20.87%
197.55 %+134.78%
84.14 %-41.20%
143.10 %+93.04%
74.13 %-14.93%
87.14 %-5.92%
92.62 %+34.98%
68.62 %-37.69%
110.13 %+6.33%
103.57 %-26.25%
140.43 %+12.76%
124.54 %-68.18%
391.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

CapEx to Operating Cash Flow Ratio of JMS Co is 156.31 % in 2026.

CapEx to Operating Cash Flow Ratio of JMS Co changed from 197.55 % to 156.31 %, representing a -20.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio JMS Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — JMS Co

All Key Metrics — JMS Co